Nomination Committee appointed for the Annual General Meeting 2020
The members of the Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Tuesday 28 April 2020 at the company’s headoffice in Botkyrka, have now been appoined.
The Nomination Committee for the 2020 Annual General Meeting in Bactiguard Holding AB (publ) will consist of the following members:
Jan Ståhlberg, Chairman of the Board of Directors
Helena Borglund, appointed by KK Invest AB and Chairman of the Nomination Committe
Thomas von Koch, appointed by Bactiguard B.V.
Mats J Andersson, appointed by Nordea Fonder
Per Colleen, appointed by Fjärde AP Fonden
In accordance with the instructions for the Nomination Committee in Bactiguard Holding AB (publ), the Nomination Committee shall consist of five members. The chairman of the Board of Directors shall contact the four largest shareholders of the company, in terms of voting power, pursuant to Euroclear Sweden AB’s print out of the share register on 31 August. Each of the four largest shareholders shall be offered the opportunity to, within reasonable time, appoint a member who, together with the chairman of the Board, will constitute the Nomination Committee.
The Nomination Committee will prepare proposals for the Annual General Meeting in 2020 regarding Chairman of the Annual General Meeting, Board members, Chairman of the Board, remuneration for Board members, Auditor, Auditor’s fees and, to the extent deemed necessary, proposal regarding amendments to the current instruction for the Nomination Committee.
Shareholders who wish to make proposals to the Nomination Committee can do so by writing to the Nomination Committee under the following address:
Nomination Committee
Bactiguard Holding AB (publ)
Box 15
146 21 Tullinge
Proposals can also be sent by email to the following address: valberedningen@bactiguard.se
In order for the Nomination Committee to be able to address proposals in a constructive manner, they should have been received by 31 January, 2020.
The proposals of the Nomination Committee will be presented in the invitation to the Annual General Meeting and at the company’s website.
For further information, please contact:
Cecilia Edström, CFO and deputy CEO
mobile phone: +46 72 226 23 28
About Bactiguard
Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission, we develop and supply infection prevention solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large.
The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner BD, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.
Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. The company has about 70 employees around the world. Its headquarters and one of two production facilities are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm.
Read more about how Bactiguard saves lives at www.bactiguard.com